Related Experiment Videos
Intrahepatic sarcomatous cholangiocarcinoma
H Imazu1, M Ochiai, T Funabiki
1Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.
Journal of Gastroenterology
|October 1, 1995
Summary
This study details a rare case of intrahepatic cholangiocarcinoma with secondary sarcomatous transformation, initially presenting as a liver tumor. Advanced imaging and histopathology confirmed its epithelial origin, distinguishing it from hepatocellular carcinoma.
Area of Science:
- Hepatobiliary pathology
- Surgical oncology
- Diagnostic imaging
Background:
- Distinguishing between primary liver tumors like hepatocellular carcinoma and intrahepatic cholangiocarcinoma is crucial for treatment.
- Secondary sarcomatous transformation in cholangiocarcinoma is a rare phenomenon that can alter tumor presentation and behavior.
Observation:
- A 77-year-old male presented with a liver tumor. Imaging revealed a 7 cm low-density mass with specific enhancement patterns on CT and MRI.
- Angiography showed hepatic artery stretching and an avascular area, suggesting a specific tumor vascularity.
- Histopathological examination of the resected tumor showed spindle and round cells without glandular formation, positive for keratin and vimentin, and CEA-positive, AFP-negative.
Findings:
- The tumor exhibited features suggestive of epithelial origin with resemblance to regenerating bile ducts.
- Immunohistochemical staining confirmed positivity for keratin and vimentin, and carcinoembryonic antigen (CEA), while being negative for alpha-fetoprotein (AFP).
- The final diagnosis was intrahepatic cholangiocarcinoma with secondary sarcomatous transformation.
Implications:
- Accurate diagnosis of intrahepatic cholangiocarcinoma with sarcomatous change is vital for appropriate patient management and prognosis.
- This case highlights the importance of integrating advanced imaging and detailed histopathological analysis for complex liver tumors.
- Understanding the distinct cellular and molecular characteristics aids in differentiating it from hepatocellular carcinoma, guiding therapeutic strategies.